Drug Shortage Report for OXYTOCIN INJECTION, USP

Last updated on 2022-11-02 History
Report ID 167490
Drug Identification Number 02139561
Brand name OXYTOCIN INJECTION, USP
Common or Proper name OXYTOCIN INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 mL
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-01
Estimated end date 2022-11-14
Actual end date 2022-11-01
Shortage status Resolved
Updated date 2022-11-02
Company comments As previously communicated, our 10mL vial will be placed on 100% allocation in October. Contract customers will be allocated 100% of 10 mL historical monthly demand with no coverage of 1 mL possible. As the 10 mL inventory currently in circulation expires on September 30, 2022, we will be releasing October allocations on September 27, 2022 to allow early access to better dated inventory. Any quantities purchased the week of September 27, 2022 will be reduced from October allocations. Please note, newly released inventory will expire on January 31, 2023 and we anticipate fresh inventory of 10mL to be available by November 14, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-11-02 French Compare
v7 2022-11-02 English Compare
v6 2022-10-02 English Compare
v5 2022-09-26 French Compare
v4 2022-09-26 English Compare
v3 2022-09-26 English Compare
v2 2022-08-19 French Compare
v1 2022-08-19 English Compare

Showing 1 to 8 of 8